As the coordinating center for the international Preclinical Design and Clinical Translation of Regimens for Tuberculosis (PReDiCTR-TB) Consortium, the laboratory integrates computational science, predictive modeling, translational pharmacology, clinical data, and quantitative decision science to support regimen selection, dose optimization, clinical trial design, and model-informed decision-making across the drug development lifecycle. The Savic Integrated Pharmacology Laboratory in the Department of Bioengineering and Therapeutic Sciences at the University of California, San Francisco (UCSF) is a global leader in model-informed drug development (MIDD) for infectious diseases and serves as an innovation hub for translational pharmacology, quantitative systems pharmacology (QSP), pharmacometrics, machine learning, artificial intelligence, and mechanistic modeling.